MycoMed Technologies, LLC

MycoMed is focused on the development and commercialization of diagnostic tests and treatments for fungal infections. Over the past decade there has been a surge in fungal lung infections. The company’s mission is to assist clinicians in the early detection of infections so as to elicit early treatment intervention to improve patient outcomes. MycoMed’s lead product is a direct antigen test for the detection of Aspergillus infection.